Medivir to present at the Carlsquare Equity Research Investor Day
STOCKHOLM, Dec. 6, 2023 /PRNewswire/ — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will present at the Carlsquare Equity Research Investor Day, today December 6, 2023.
Related news for (IGMS)
- 24/7 Market News Snapshot 01 July, 2025 – IGM Biosciences, Inc. Common Stock (NASDAQ:IGMS)
- IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right
- 24/7 Market News Snapshot 01 July, 2025 – IGM Biosciences, Inc. Common Stock (NASDAQ:IGMS)
- IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs
- igm biosciences announces strategic pivot to focus exclusively on autoimmunity
